In 2021, Prestige Consumer Healthcare completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Prestige Consumer Healthcare has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2021 |
|---|---|
Total Scope 1 | 1,304a |
Total Scope 2 | |
Market-Based | 5,530a |
Location-Based | N/A |
Total Scope 3 | 100,330a |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 1.3823a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2021, the total operational greenhouse gas (GHG) emissions of Prestige Consumer Healthcare amounted to 6,834 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
In 2021, the total Scope 1 emissions of Prestige Consumer Healthcare were 1,304 metric tons of CO₂ equivalent (tCO₂e).a
In 2021, Prestige Consumer Healthcare reported Scope 2 greenhouse gas (GHG) emissions of 5,530 tCO₂e using the market-based method.a
In 2021, Prestige Consumer Healthcare reported its Scope 2 emissions using the market-based method.a
In 2021, Prestige Consumer Healthcare reported 100,330 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2021 disclosure of Prestige Consumer Healthcare includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in , demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2021, Prestige Consumer Healthcare reported total Scope 3 emissions of 100,330 metric tons of CO₂ equivalent (tCO₂e).a
In 2021, Prestige Consumer Healthcare reported Scope 1 greenhouse gas (GHG) emissions of 1,304 tCO₂e and total revenues of USD 943 millions. This translates into an emissions intensity of 1.38 tCO₂e per millions USD.a
In 2021, Prestige Consumer Healthcare reported a Scope 1 emissions intensity of 1.38 tCO₂e per millions USD. Compared to the peer group median of 12.23, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2021, Prestige Consumer Healthcare ranked 1 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Prestige Consumer Healthcare among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2021, Prestige Consumer Healthcare reported a total carbon footprint of 107,164 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions.a
The largest contributor to Prestige Consumer Healthcare's total carbon footprint was Scope 3 emissions, accounting for 93.62% of the company's total carbon footprint, followed by Scope 2 emissions at 5.16%.a